scorecardresearch
Add as a preferred source on Google
Sunday, November 30, 2025
TopicBiocon

Topic: Biocon

India prepares to test Itolizumab, the drug credited for lowering Covid mortality in Cuba

The drug will go under trial in six hospitals in India, including AIIMS-Delhi, KEM Hospital in Mumbai and Narayana Health in Bengaluru. 

Biocon’s blood purification device gets regulator nod for treating critical Covid patients

CytoSorb was introduced in 2013 for Sepsis patients. It has now been allowed to treat critical Covid patients to help reduce their cytokines levels.

Made-in-India Covid-19 vaccine could be ready in a year, says Biocon’s Kiran Mazumdar-Shaw

In an interview to ThePrint, Biocon co-founder Kiran Mazumdar-Shaw says India is ahead of other countries in flattening the Covid-19 curve.

On Camera

There’s pollution, violence, volcanic ash on my screen. And yet an email is more stressful

Years are quietly being stripped off my lifespan, and somehow that doesn’t ruin my day. But getting scolded for one careless word in an email? That can send me spiralling.

Karnataka startups feel the chill as global funding winter sets in. Fintech emerges as sole bright spot

The state raises just $2.7 billion in first nine months of 2025 compared to $4.5 billion last year, with late-stage investments hit hardest.

What’s expected from Putin’s India visit in December—Defence Secretary explains

ThePrint had previously reported that India & Russia are talking about 5 more regiments of the S-400, but no contracts are to be signed during the Russian president's visit.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.